| Literature DB >> 33298037 |
Ulla-Maija Oivio1, Paula Pesonen2, Merja Ylipalosaari3, Arja Kullaa4,5, Tuula Salo6,7,8,9.
Abstract
BACKGROUND: In this cross-sectional study we investigated the oral mucosal changes in a middle-aged Finnish population. We analyzed the prevalence of potentially malignant disorders and the influence of smoking, snuff and alcohol use on the mucosal changes.Entities:
Keywords: Cross-sectional study; Leukoplakia; Middle-aged population; NFBC; Normal variations and lesions; Oral lichen planus; Oral lichenoid reaction; Oral mucosa; Prevalence
Year: 2020 PMID: 33298037 PMCID: PMC7727189 DOI: 10.1186/s12903-020-01351-9
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Characteristics of the study population
| Total | Male | Female | |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Current smoker | 343 (18.3) | 167 (19.2) | 176 (17.5) |
| Former smoker | 534 (28.5) | 291 (33.4) | 243 (24.2) |
| Non-smoker | 999 (53.3) | 413 (47.4) | 586 (58.3) |
| Regular user | 31 (1.6) | 30 (3.4) | 1 (0.1) |
| Occasional user | 39 (2.1) | 38 (4.3) | 1 (0.1) |
| Non-user | 1820 (96.3) | 810 (92.3) | 1010 (99.8) |
| Heavy user | 232 (12.2) | 150 (17.0) | 82 (8.0) |
| Normal user | 1673 (87.8) | 732 (83.0) | 941 (92.0) |
Oral mucosal normal variations and lesions
| Total | Male | Female | ||
|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||
| No changes | 1755 (89.5) | 803 (88.1) | 952 (90.7) | 0.069 |
| Normal variations | 64 (3.3) | 37 (4.1) | 27 (2.6) | 0.064 |
| Vesiculobullous lesions | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Ulcerative lesions | 4 (0.2) | 3 (0.3) | 1 (0.1) | 0.343 |
| White lesions | 128 (6.5) | 74 (8.1) | 54 (5.1) | 0.008 |
| Red-blue lesions | 25 (1.3) | 12 (1.3) | 13 (1.2) | 0.876 |
| Pigmented lesions | 13 (0.7) | 3 (0.3) | 10 (1.0) | 0.090 |
| Verruca-papillary lesions | 3 (0.2) | 2 (0.2) | 1 (0.1) | 0.600 |
| CTL: tongue and buccal mucosal swellings | 18 (0.9) | 9 (1.0) | 9 (0.9) | 0.762 |
| CTL: gingival swellings | 5 (0.3) | 3 (0.3) | 2 (0.2) | 0.668 |
| CTL: floor of mouth swellings | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
CTL = connective tissue lesions
Prevalence of normal oral mucosal variations and their distribution by sex
| Total | Male | Female | ||
|---|---|---|---|---|
| n = 1961 | n = 911 | n = 1050 | ||
| n (%) | n (%) | n (%) | ||
| Fordyce granules | 24 (1.2) | 21 (2.3) | 3 (0.3) | < 0.001 |
| Fissured tongue | 22 (1.1) | 8 (0.9) | 14 (1.3) | 0.340 |
| Geographic tongue | 18 (0.9) | 6 (0.7) | 12 (1.1) | 0.262 |
| Hairy tongue | 3 (0.2) | 2 (0.2) | 1 (0.1) | 0.600 |
| Linea alba | 2 (0.1) | 1 (0.1) | 1 (0.1) | 1.000 |
| Erythema migrans (lip) | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Exostosis | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Melanotic macule | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Mandible exostosis | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Dry lips | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
Prevalence of oral mucosal lesions and their distribution by sex
| Total | Male | Female | ||
|---|---|---|---|---|
| n = 1961 | n = 911 | n = 1050 | ||
| n (%) | n (%) | n (%) | ||
| OLR | 39 (2.0) | 25 (2.7) | 14 (1.3) | 0.026 |
| OLP | 29 (1.5) | 11 (1.2) | 18 (1.8) | 0.354 |
| Hyperkeratosis | 14 (0.7) | 9 (1.0) | 5 (0.5) | 0.179 |
| Fibroma | 13 (0.7) | 6 (0.7) | 7 (0.7) | 0.983 |
| Snuff-related lesion | 10 (0.5) | 10 (1.0) | 0 (0.0) | < .001 |
| Amalgam pigmentation | 7 (0.4) | 1 (0.1) | 6 (0.6) | 0.131 |
| Median rhomboid glossitis | 7 (0.4) | 4 (0.4) | 3 (0.3) | 0.711 |
| Candidiasis + thrush | 6 (0.3) | 5 (0.5) | 1 (0.1) | 0.103 |
| Hemangioma | 6 (0.3) | 3 (0.3) | 3 (0.3) | 1.000 |
| Ulcer | 6 (0.3) | 3 (0.3) | 3 (0.3) | 1.000 |
| Hematoma | 5 (0.3) | 2 (0.2) | 3 (0.3) | 1.000 |
| Rhagards | 4 (0.2) | 2 (0.2) | 2 (0.2) | 1.000 |
| Hyperpigmentation | 3 (0.2) | 1 (0.1) | 2 (0.2) | 1.000 |
| Leukoplakia | 9 (0.5) | 6 (0.7) | 3 (0.3) | 0.318 |
| Papilloma | 3 (0.2) | 2 (0.2) | 1 (0.1) | 0.600 |
| Petechia | 3 (0.2) | 2 (0.2) | 1 (0.1) | 0.600 |
| Foliate papilla hyperplasia | 2 (0.1) | 0 (0.0) | 2 (0.2) | 0.502 |
| Tongue papilla atrophy | 2 (0.1) | 0 (0.0) | 2 (0.2) | 0.502 |
| Oral mucocele/ranula | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Linea alba | 2 (0.1) | 1 (0.1) | 1 (0.1) | 1.000 |
| Erythema | 2 (0.1) | 1 (0.1) | 1 (0.1) | 1.000 |
| Fistula | 2 (0.1) | 1 (0.1) | 1 (0.1) | 1.000 |
| Tobacco hyperpigmentation | 2 (0.1) | 1 (0.1) | 1 (0.1) | 1.000 |
| Aphthous ulcer | 2 (0.1) | 1 (0.1) | 1 (0.1) | 1.000 |
| Gingiva hyperplasia | 2 (0.1) | 2 (0.2) | 0 (0.0) | 0.216 |
| Prosthesis stomatitis | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Mucosal burn | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Glandula sublingualis swelling | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Salivary calculus | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Papular hyperplasia | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Tongue papule | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| White drug reaction (antibiotics) | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Cheek mucosa hyperplasia | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Bite trauma | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Cobblestone hyperplasia | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Desquamative gingivitis | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Hairy leukoplakia | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Herpes simplex infection | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Nicotine stomatitis | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Non-homogenous leukoplakia | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Palatal ulcer | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Papilla incisor hyperplasia | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Redness of papilla incisor | 1 (0.1) | 0 (0.0) | 1 (0.1) | 1.000 |
| Solar cheilitis | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
| Tongue hypertrophy | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.465 |
Lesions associated with smoking and sex
| Current smoker | Former smoker | Non-smoker | ||
|---|---|---|---|---|
| n = 343 | n = 534 | n = 999 | ||
| n (%) | n (%) | n (%) | ||
| Male | 3 (1.8) | 3 (1.0) | 3 (0.7) | 0.500 |
| Female | 9 (5.1) | 2 (0.8) | 6 (1.0) | 0.002 |
| Total | 12 (3.5) | 5 (0.9) | 9 (0.9) | 0.001 |
| | 0.095 | 1.000 | 0.743 | |
| Male | 8 (4.8) | 7 (2.4) | 10 (2.4) | 0.255 |
| Female | 6 (3.4) | 2 (0.8) | 6 (1.0) | 0.070 |
| Total | 14 (4.1) | 9 (1.7) | 16 (1.6) | 0.016 |
| | 0.518 | 0.192 | 0.083 | |
| Male | 3 (1.8) | 2 (0.7) | 1 (0.2) | 0.092 |
| Female | 2 (1.1) | – | 1 (0.2) | 0.125 |
| Total | 5 (1.5) | 2 (0.4) | 2 (0.2) | 0.024 |
| | 0.678 | 0.503 | 1.000 | |
| Male | 4 (2.4) | 1 (0.3) | 2 (0.5) | 0.046 |
| Female | 2 (1.1) | 3 (1.2) | 0 (0.0) | 0.029 |
| Total | 6 (1.7) | 4 (0.7) | 2 (0.2) | 0.007 |
| | 0.374 | 0.335 | 0.171 | |
| Male | 1 (0.6) | 0 (0.0) | 0 (0.0) | 0.192 |
| Female | 1 (0.6) | 0 (0.0) | 0 (0.0) | 0.175 |
| Total | 2 (0.6) | 0 (0.0) | 0 (0.0) | 0.033 |
| | 1.000 | – | – | |
| Male | 5 (3.0) | 4 (1.4) | 1 (0.2) | 0.013 |
| Female | 0 (0.0) | 0 (0.0) | 0 (0.0) | – |
| Total | 5 (1.5) | 4 (0.7) | 1 (0.1) | 0.004 |
| | 0.027 | 0.130 | 0.413 | |
| Male | 0 (0.0) | 1 (0.3) | 5 (1.2) | 0.341 |
| Female | 2 (1.1) | 0 (0.0) | 10 (1.7) | 0.089 |
| Total | 2 (0.6) | 1 (0.2) | 15 (1.5) | 0.031 |
| | 0.499 | 1.000 | 0.526 | |
| Male | 2 (1.2) | 4 (1.4) | 13 (3.1) | 0.178 |
| Female | 1 (0.6) | 0 (0.0) | 2 (0.3) | 0.555 |
| Total | 3 (0.9) | 4 (0.7) | 15 (1.5) | 0.364 |
| | 0.614 | 0.130 | < 0.001 | |
aComparation between smoking
bComparation between sexes
Crude ORs and 95% CIs for any mucosal changes or diseases in association with smoking, snuff and alcohol comparing current smokers and former smokers to non-smokers, snuff users to non-snuff users and alcohol heavy users to normal users
| Crude OR (95% CI) | Adjusted OR (95% CI) | |||
|---|---|---|---|---|
| Current smoker | 3.0 (2.11–4.28) | < 0.001 | 2.9 (2.03–4.18) | < |
| Former smoker | 1.3 (0.93–1.93) | 0.120 | 1.3 (0.89–1.87) | 0.178 |
| Non-smoker (reference) | 1.0 | 1.0 | ||
| Use occasionally or regularly | 2.6 (1.48–4.70) | 0.001 | 2.4 (1.31–4.36) | |
| Non-snuff user (reference) | 1.0 | 1.0 | ||
| Heavy user | 1.3 (0.82–1.91) | 0.290 | 0.9 (0.59–1.43) | 0.703 |
| Normal user (reference) | 1.0 | 1.0 | ||